ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,263Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 36

$896K Total Retail Price of All Prescriptions

Rank: 6 out of 36

600 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 600 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

4% of this provider’s 600 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 15,468 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 612 593 1 3
SIMVASTATIN 609 572 2 1
AMLODIPINE BESYLATE 595 565 3 2
FUROSEMIDE 584 574 4 4
WARFARIN SODIUM 491 490 5 5
DONEPEZIL HCL 429 429 6 10
OMEPRAZOLE 329 312 7 6
POTASSIUM CHLORIDE 326 314 8 19
ESCITALOPRAM OXALATE 320 301 9 22
LISINOPRIL 312 311 10 7
LACTULOSE 292 270 11 27
NAMENDA 277 277 12 12
METOPROLOL TARTRATE 257 247 13 8
LOSARTAN POTASSIUM 249 239 14 26
ATORVASTATIN CALCIUM 239 230 15 13
MIRTAZAPINE 224 224 16 16
METOPROLOL SUCCINATE 217 215 17 11
SERTRALINE HCL 193 191 18 15
ATENOLOL 173 173 19 18
SANTYL 155 155 20 72
HYDROCHLOROTHIAZIDE 152 135 21 14
DIGOXIN 152 152 21 46
FENTANYL 148 147 S2 23 43
PANTOPRAZOLE SODIUM 147 147 24 32
TAMSULOSIN HCL 145 145 25 23
METFORMIN HCL 138 114 26 9
QUETIAPINE FUMARATE 135 128 27 38
ZOLPIDEM TARTRATE 125 125 28 25
LIDODERM 123 105 29 41
RANITIDINE HCL 122 108 30 62
DIOVAN 121 118 31 36
CLOPIDOGREL 120 120 32 30
LEVETIRACETAM 117 102 33 49
FAMOTIDINE 113 104 34 17
GABAPENTIN 112 112 35 20
PREDNISONE 109 109 36 55
CARVEDILOL 107 83 37 21
CRESTOR 101 101 38 50
RISPERIDONE 100 100 39 28
LEXAPRO 100 94 39 106
ALBUTEROL SULFATE 99 97 41 40
MELOXICAM 96 96 42 63
IPRATROPIUM-ALBUTEROL 94 85 43 51
ALENDRONATE SODIUM 93 90 44 33
AZITHROMYCIN 91 88 45 66
SPIRIVA 89 89 46 73
ALLOPURINOL 89 88 46 59
CITALOPRAM HBR 89 89 46 31
LOVAZA 88 74 49 92
ZETIA 83 78 50 148
LANTUS 82 82 51 43
SODIUM CHLORIDE 81 81 52 166
CYMBALTA 80 80 53 80
LATANOPROST 75 75 54 97
ADVAIR DISKUS 74 73 55 45
CIPROFLOXACIN HCL 74 70 55 64
POLYETHYLENE GLYCOL 3350 73 69 57 85
PLAVIX 72 72 58 42
OXYCODONE-ACETAMINOPHEN 71 71 S2 59 29
OLANZAPINE 68 68 60 86
LEVOFLOXACIN 66 63 61 68
PAROXETINE HCL 60 48 62 57
CARBIDOPA-LEVODOPA 60 50 62 71
NEXIUM 60 60 62 35
LIPITOR 59 53 65 78
LYRICA 59 59 65 88
DIOVAN HCT 57 57 67 118
NYSTATIN 56 54 68 117
BISOPROLOL FUMARATE 56 56 68 157
JANUVIA 55 41 70 47
DOXAZOSIN MESYLATE 55 55 70 100
NOVOLOG 55 55 70 98
SEROQUEL 55 52 70 105
SODIUM BICARBONATE 54 0 10 74 248
ENALAPRIL MALEATE 54 52 74 24
TRAZODONE HCL 54 54 74 54
VESICARE 52 52 77 155
SYNTHROID 52 52 77 56
DIVALPROEX SODIUM 50 50 79 34
CLOTRIMAZOLE-BETAMETHASONE 50 49 79 79
IBUPROFEN 50 50 79 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.